Immune escape mechanisms associated with tumor recurrence after adoptive cell transfer immunotherapy.

被引：0
|
作者：
Donia, Marco
Andersen, Rikke
Harbst, Katja
Idorn, Manja
Munir, Shamaila
Ellebaek, Eva
Mueller, Anja
Fagone, Paolo
Nicoletti, Ferdinando
Travali, Salvatore
Hadrup, Sine Reker
Andersen, Mads Hald
Seliger, Barbara
Jonsson, Goran
Straten, Per Thor
Svane, Inge Marie
机构：
[1] Copenhagen Univ Hosp Herlev, Ctr Canc Immune Therapy, Herlev, Denmark
[2] Ctr Canc Immune Therapy, Herlev, Denmark
[3] Melanoma Genom Unit, Lund, Sweden
[4] Copenhagen Univ Hosp Herlev, Dept Oncol, Herlev, Denmark
[5] Copenhagen Univ Hosp Herlev, Ctr Canc ImmuneTherapy, Dept Hematol, Herlev, Denmark
[6] Univ Halle Wittenberg, Inst Med Immunol, D-06108 Halle, Germany
[7] Univ Catania, Dept Biomed Sci, Catania, Italy
[8] Ctr Canc Immune Therapy, Copenhagen, Denmark
[9] Lund Univ, Dept Oncol, Inst Clin Sci, Lund, Sweden
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2014年 / 32卷 / 15期
关键词：
D O I：
10.1200/jco.2014.32.15_suppl.3054
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3054
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Mathematical modeling of tumor immune escape identifies beneficial conditions of immunotherapy.
    Haeno, Hiroshi
    CANCER SCIENCE, 2022, 113 : 1482 - 1482
  • [2] Restoration of immune mediated hearing loss by adoptive immunotherapy.
    Zhou, Bin
    Kermany, Mohammad
    Cai, Chun
    Cai, Qing
    Tarner, Ingo
    Fathman, Garrison
    Yoo, Tai June
    CLINICAL IMMUNOLOGY, 2006, 119 : S81 - S81
  • [3] Differential immune susceptibility of malignant versus normal tissue leads to tumor rejection without GVH after adoptive immunotherapy.
    Delisle, JS
    Meunier, MC
    Barron, C
    Bergeron, J
    Perreault, C
    BLOOD, 2004, 104 (11) : 832A - 832A
  • [4] Improving the outcome of adoptive cell transfer by targeting tumor escape
    Kaluza, Karen M.
    Vile, Richard
    ONCOIMMUNOLOGY, 2013, 2 (01):
  • [5] Generation and enrichment of antigen-specific cytotoxic T lymphocytes for adoptive transfer in tumor immunotherapy.
    Oelke, M
    Vogl, S
    Cerundolo, V
    Andreesen, R
    Mackensen, A
    BLOOD, 2000, 96 (11) : 28A - 28A
  • [6] Autophagy in tumor immune escape and immunotherapy
    Wang, Huan
    Sun, Peng
    Yuan, Xijing
    Xu, Zhiyong
    Jiang, Xinyuan
    Xiao, Mingshu
    Yao, Xin
    Shi, Yueli
    MOLECULAR CANCER, 2025, 24 (01)
  • [7] CTL adoptive immunotherapy concurrently mediates tumor regression and tumor escape
    Liu, Kebin
    Caldwell, Sheila A.
    Greeneltch, Kristy M.
    Yang, Dafeng
    Abrams, Scott I.
    JOURNAL OF IMMUNOLOGY, 2006, 176 (06): : 3374 - 3382
  • [8] COMBINATION IMMUNOTHERAPY: NEUTRALIZATION OF THE TUMOR ESCAPE AND IMMUNOSUPPRESSIVE MECHANISMS MAY BE REQUIRED FOR CLINICALLY EFFECTIVE TUMOR VACCINES AND ADOPTIVE IMMUNOTHERAPY APPROACHES (AN OVERVIEW)
    Platsoucas, Chris D.
    ANTICANCER RESEARCH, 2008, 28 (5C) : 3449 - 3450
  • [9] The arginine effect on cell-mediated cytotoxicity in adoptive cellular immunotherapy.
    Ozdemir, Oner
    Ochoa, Augusto
    CLINICAL IMMUNOLOGY, 2006, 119 : S99 - S99
  • [10] Reenergized Adoptive Cell Transfer Immunotherapy
    Kaiser, Carl
    Klestinski, Keith
    Cui, Weiguo
    Chang, Mika
    Cowan, Nelson
    Smith, Sean
    Strom, Daniel
    Strom, James
    FASEB JOURNAL, 2018, 32 (01):
12345